Cargando…
Advanced Nanoparticle-Based Drug Delivery Systems and Their Cellular Evaluation for Non-Small Cell Lung Cancer Treatment
SIMPLE SUMMARY: Nanoparticulate systems have been extensively explored for the treatment of various diseases, including cancers. The outstanding characteristics of nanoparticles have made it possible to administer them via different routes such as intravenous or inhalation. This flexibility can impr...
Autores principales: | Mohtar, Noratiqah, Parumasivam, Thaigarajan, Gazzali, Amirah Mohd, Tan, Chu Shan, Tan, Mei Lan, Othman, Rozana, Fazalul Rahiman, Siti Sarah, Wahab, Habibah A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8303683/ https://www.ncbi.nlm.nih.gov/pubmed/34298753 http://dx.doi.org/10.3390/cancers13143539 |
Ejemplares similares
-
Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview
por: A. Razak, S. Aishah, et al.
Publicado: (2021) -
Eurycoma longifolia: an overview on the pharmacological properties for the treatment of common cancer
por: Jothi, Shankar, et al.
Publicado: (2023) -
Pulmonary Delivery of Anticancer Drugs via Lipid-Based Nanocarriers for the Treatment of Lung Cancer: An Update
por: Abdulbaqi, Ibrahim M., et al.
Publicado: (2021) -
Conjugated β-Cyclodextrin Enhances the Affinity of Folic Acid towards FRα: Molecular Dynamics Study
por: Al-Thiabat, Mohammad G., et al.
Publicado: (2021) -
Heterocyclic Substitutions Greatly Improve Affinity and Stability of Folic Acid towards FRα. an In Silico Insight
por: Al-Thiabat, Mohammad G., et al.
Publicado: (2021)